|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2007-12-14 Purchase |
2007-12-17 5:57 pm | GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 10,000 | $0.8696 | $8,696 | 83,785 (Direct) | View |
| 2006-09-29 Purchase |
2006-11-16 5:01 pm | GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 2,621 | $1.24 | $3,250 | 65,412 (Direct) |
View |
| 2005-11-11 Purchase |
2005-11-15 09:22 am |
GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 3,000 | $1.613 | $4,840 | 62,791 (Direct) |
View |
| 2005-05-16 Purchase |
2005-05-16 4:29 pm | GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 3,000 | $1.32 | $3,960 | 59,791 (Direct) |
View |
| 2005-03-14 Purchase | 2005-03-15 4:20 pm |
GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 5,000 | $1.75 | $8,750 | 56,791 (Direct) | View |
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price | Total Amount |
Shares Ownership | Filing |
| 2008-09-26 Option Award | 2008-09-29 4:15 pm |
GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 7,432 | $0.37 | $2,750 | 106,219 (Direct) | View |
| 2008-06-27 Option Award | 2008-06-30 5:17 pm | GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 6,841 | $0.402 | $2,750 | 98,787 (Direct) | View |
| 2008-03-28 Option Award | 2008-04-01 4:40 pm | GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 5,000 | $0.55 | $2,750 | 91,946 (Direct) |
View |
| 2007-12-28 Option Award | 2007-12-28 5:05 pm | GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 3,161 | $0.87 | $2,750 | 86,946 (Direct) |
View |
| 2007-09-28 Option Award | 2007-10-02 5:39 pm | GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 2,696 | $1.02 | $2,750 | 73,785 (Direct) |
View |
| 2007-06-29 Option Award |
2007-07-02 4:56 pm | GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 2,391 | $1.15 | $2,750 | 71,089 (Direct) |
View |
| 2007-03-30 Option Award |
2007-04-03 4:25 pm |
GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 1,709 | $1.024 | $1,750 | 68,698 (Direct) |
View |
| 2006-12-29 Option Award |
2007-01-03 4:45 pm |
GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 1,577 | $1.11 | $1,750 | 66,989 (Direct) |
View |
| 2004-03-19 Option Award | 2004-03-19 7:27 pm | GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 1,000 | $2.141 | $2,141 | 51,791 (Direct) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded | Conversion Price | Shares Ownership | Filing |
| 2008-05-22 Option Award | 2008-05-27 12:29 pm |
2008-05-22 2018-05-22 |
GENZYME CORP | GENZ | GERAGHTY JAMES A (Senior Vice President) | 15,000 | $68.48 | 15,000 (Direct) | View |
| 2008-05-22 Option Award |
2008-05-27 12:29 pm | 2011-05-22 N/A |
GENZYME CORP | GENZ | GERAGHTY JAMES A (Senior Vice President) | 5,000 | $0 | 5,000 (Direct) |
View |
| 2007-05-23 Option Award |
2007-05-25 4:04 pm |
N/A 2017-05-23 |
GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 45,000 | $1.18 | 45,000 (Direct) | View |
| 2004-05-26 Option Award | 2004-05-28 4:03 pm | N/A 2014-05-26 |
GTC BIOTHERAPEUTICS INC | GTCB | GERAGHTY JAMES A (Director) | 22,500 | $1.75 | 22,500 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Fri, 05 Dec 2008 04:22:38 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |